- Jan 22/21
Detailed map of the skin points to new drug targets for inflammatory diseases - Jan 21/21
Medicine by Design and H2i form partnership to support entrepreneurs in regenerative medicine - Jan 21/21
Using gene therapy to mimic the effects of physical exercise - Jan 21/21
Reviving exhausted T cells gets them back in the fight against cancer - Jan 21/21
FDA guides on COVID-19 considerations in cell and gene therapy - Jan 20/21
A novel CAR T-cell therapy to treat lymphomas - Jan 20/21
CRISPR technology to cure sickle cell disease at UIC - Jan 19/21
Genome editing to treat human retinal degeneration - Jan 19/21
Parent Project Muscular Dystrophy invests $1 million in Satellos Bioscience to support new regenerative medicine technology - Jan 19/21
Gilead’s Kite Pharma unit nabs Marincola to head up its cell therapy research - Jan 19/21
UKRI shares Canadian opportunities for UK advanced therapy firms - Jan 18/21
Gene therapy allows paralyzed mice to walk again - Jan 18/21
Starving cancer cells through the cell’s “powerhouse” - Jan 15/21
Cell and gene therapies shatter prior records, with continued growth expected - Jan 15/21
One step closer to CRISPR-Cas9 cancer therapies - Jan 15/21
Umbilical cord stem cells show promise as COVID-19 therapy - Jan 15/21
Thermo Fisher takes deep dive into cell and gene therapy with viral vector business buy - Jan 15/21
Study supports reversal of vision loss from glaucoma - Jan 14/21
Stem cell transplant for blindness, retina disease nears human assessment - Jan 14/21
Big step forward for planned centre to boost cell- and gene-therapy advances - Jan 14/21
New gene therapy methods deliver promise - Jan 14/21
Development “cookbooks” could speed up gene therapy - Jan 14/21
Scientists are a step closer to developing “smart” stem cells – and they’re made from human fat - Jan 13/21
Sanofi: “Vaccine heritage puts us in good stead to play in gene therapy space” - Jan 12/21
New antibody discovery platform could help accelerate CAR-T therapeutic development - Jan 12/21
Recipient of $22 million from [California’s] stem cell agency named to its board - Jan 12/21
Hope for children with rare heart condition: novel stem cell therapy - Jan 12/21
Australia advances infrastructure investments in diabetes, cardiovascular, regenerative therapies - Jan 12/21
New approach to CAR T-cell therapy developed to fight lymphomas - Jan 12/21
Researchers develop new technique to more efficiently isolate and identify rare T cells - Jan 11/21
Tackling the next hurdle in cell and gene therapy: manufacturing - Jan 9/21
Advances in research on the most general type of stem cells - Jan 8/21
5 questions facing gene therapy in 2021 - Jan 8/21
“Invisible” stem cells evade natural killer cells using immune “off-switch” - Jan 8/21
Scientists develop new gene therapy strategy to delay aging - Jan 8/21
Accelerating cell-based therapies by providing safe therapeutic MSC products - Jan 8/21
If athletes can edit their own DNA, how will we detect it? - Jan 7/21
ExCellThera announces UM171 mechanism of action - Jan 7/21
FDA offers first thoughts on neurodegenerative disease gene therapies - Jan 7/21
Regenerative heart valves and blood vessels a step closer - Jan 7/21
Pfizer beats Sarpeta to start of first late-stage Duchenne gene therapy trial - Jan 7/21
Spiny mouse that can regenerate skin without leaving scars shows potential for human therapy - Jan 6/21
Leading $105M biotech funding, Bayer deepens cell therapy investment - Jan 6/21
Biogen pushes further into gene therapy for the eye with new deal - Jan 6/21
Inside AVROBIO’s approach to gene therapy manufacturing automation - Jan 6/21
“Incredible” gene editing result in mice inspires plans to treat premature-aging syndrome in children - Jan 6/21
UK-US alliance explores gene therapies to avert blindness - Jan 6/21
Top life sciences startups to watch in 2021 - Jan 6/21
Gene therapy offers hope for a common cause of mitochondrial blindness - Jan 5/21
“The next big step”: U of T researchers pursue a treatment for vision loss - Jan 5/21
Breakthrough treatment using [mesenchymal] stem cells for extreme COVID-19 - Jan 5/21
FUJIFILM to invest $40 million in innovative viral vector and advanced therapy facility - Jan 4/21
Strategy to boost CAR T cell efficacy against solid tumours demonstrated in mice - Jan 4/21
Good results from trial of CAR T cell therapy for non-Hodgkin lymphoma - Jan 4/21
Krystal Biotech appoints Dr. Chris Mason to its Board of Directors - Jan 4/21
Boosting T cells’ ability to attack solid tumours - Jan 2/21
Gene therapy: Critics must let full picture emerge before latching on to case of liver tumour in recipient
